πŸ‡ΊπŸ‡Έ FDA
Patent

US 6887976

Glycopeptide phosphonate derivatives

expired A61KA61K38/14A61K47/06

Quick answer

US patent 6887976 (Glycopeptide phosphonate derivatives) held by Theravance, Inc. expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue May 03 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/14, A61K47/06, A61K47/12, A61K47/26